Table 2.
Intra-individual stability of a “confirmed” eGFR decline ≥ 30% over time.
| n = 860 | Confirmed eGFR decline ≥ 30% from baseline until | |||
|---|---|---|---|---|
| 1st and 2nd FU | 3rd FU | 4th FU | 5th FU | |
| n (%) | 6 (100%) | 4 (66.7%) | 4 (66.7%) | 4 (66.7%) |
| 1st FU | 2nd and 3rd FU | 4th FU | 5th FU | |
| n (%) | 4 (13.8%) | 29 (100%) | 20 (69.0%) | 16 (55.2%) |
| 1st FU | 2nd FU | 3rd and 4th FU | 5th FU | |
| n (%) | 4 (9.1%) | 20 (45.5%) | 44 (100%) | 33 (75.0%) |
| 1st FU | 2nd FU | 3rd FU | 4th and 5th FU | |
| n (%) | 4 (7.5%) | 16 (30.2%) | 33 (62.3%) | 53 (100%) |
FU follow up.
Bold numbers: number of individuals (%) persistently meeting the definition of eGFR decline over time.